Segment, Customer and Geographical Reporting (Tables)

9 Months Ended

Jun. 30, 2018

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The Company’s segment information for the three months ended June 30, 2018 and 2017 is summarized below:

Results of Operations for the Three Months Ended June 30,
2018
	Optics			Contract ‎Research			Biomedical			Total
Revenue	$	6,159,000		$	4,383,000		$	-		$	10,542,000
Gross profit		2,299,000			1,876,000			-			4,175,000
GM %		37	%		43	%		-			40	%
Operating expenses		1,721,000			1,760,000			84,000			3,565,000
Operating income (loss)		578,000			116,000			(84,000	)		610,000
Depreciation and amortization		261,000			53,000			3,000			317,000
Capital expenditures		707,000			76,000			20,000			803,000
Intangibles, net		408,000			171,000			380,000			959,000
Goodwill		968,000			4,939,000			-			5,907,000
Total assets	$	21,117,000		$	8,018,000		$	507,000		$	29,642,000

Results of Operations for the Three Months Ended June 30,
2017
		Optics			Contract ‎Research			Biomedical			Total
Revenue	$	4,837,000		$	3,999,000		$	-		$	8,836,000
Gross profit		1,655,000			1,709,000			-			3,364,000
GM %		34	%		43	%		-			38	%
Operating expenses		1,619,000			1,640,000			377,000			3,636,000
Operating income (loss)		36,000			69,000			(377,000	)		(272,000	)
Depreciation and amortization		248,000			52,000			1,000			301,000
Capital expenditures		179,000			54,000			26,000			259,000
Intangibles, net		468,000			205,000			394,000			1,067,000
Goodwill		955,000			4,939,000			-			5,894,000
Total assets	$	19,488,000		$	8,004,000		$	690,000		$	28,182,000

The Company’s segment information for the nine months ended June 30, 2018 and 2017 is summarized below:

Results of Operations for the Nine Months Ended June 30,
2018
	Optics			Contract ‎Research			Biomedical			Total
Revenue	$	17,011,000		$	12,974,000		$	-		$	29,985,000
Gross profit		6,038,000			5,621,000			-			11,659,000
GM %		35	%		43	%		-			39	%
Operating expenses		5,154,000			5,297,000			724,000			11,175,000
Operating income (loss)		884,000			324,000			(724,000	)		484,000
Depreciation and amortization		738,000			179,000			10,000			927,000
Capital expenditures		1,635,000			153,000			65,000			1,853,000
Intangibles, net		408,000			171,000			380,000			959,000
Goodwill		968,000			4,939,000			-			5,907,000
Total assets	$	21,117,000		$	8,018,000		$	507,000		$	29,642,000

Results of Operations for the Nine Months Ended June 30,
2017
		Optics			Contract ‎Research			Biomedical			Total
Revenue	$	14,524,000		$	13,541,000		$	-		$	28,065,000
Gross profit		5,144,000			5,535,000			-			10,679,000
GM %		35	%		41	%		-			38	%
Operating expenses		4,544,000			5,182,000			1,150,000			10,876,000
Operating income (loss)		600,000			353,000			(1,150,000	)		(197,000	)
Depreciation and amortization		719,000			200,000			7,000			926,000
Capital expenditures		373,000			88,000			72,000			533,000
Intangibles, net		468,000			205,000			394,000			1,067,000
Goodwill		955,000			4,939,000			-			5,894,000
Total assets	$	19,488,000		$	8,004,000		$	690,000		$	28,182,000

Schedule Of Segment Revenue By Geographical Location [Table Text Block]

Revenue by geographic location in total and as a percentage of total revenue, for the three months ended June 30, 2018 and 2017 are as follows:

	Three Months Ended					Three Months Ended
	June 30, 2018					June 30, 2017
Geographic Location	Revenue		% of Total			Revenue		% of Total
United States	$	7,512,000		71	%	$	6,928,000		78	%
Europe		2,029,000		19	%		962,000		11	%
Other		1,001,000		10	%		946,000		11	%
	$	10,542,000		100	%	$	8,836,000		100	%

Revenue by geographic location in total and as a percentage of total revenue, for the nine months ended June 30, 2018 and 2017 are as follows:

	Nine Months Ended					Nine Months Ended
	June 30, 2018					June 30, 2017
Geographic Location	Revenue		% of Total			Revenue		% of Total
United States	$	22,993,000		77	%	$	22,051,000		78	%
Europe		4,662,000		15	%		3,262,000		12	%
Other		2,330,000		8	%		2,752,000		10	%
	$	29,985,000		100	%	$	28,065,000		100	%